Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5867 posts found.

Scottish Medicines Consortium rejects Novartis’ CAR T therapy Kymriah

March 12, 2019 Manufacturing and Production Kymriah, NICE, Novartis, SMC, Scotland, UK

Scotland’s cost effectiveness body has refused to fund Novartis’ CAR T therapy Kymriah for adult patients with lymphoma. The Scottish …
News

PV futures: Pharmacovigilance as a solution to the challenges of tomorrow

March 11, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug safety, feature, pharma, pharmacovigilance

Louis Goss asks what the future might hold for the safety of pharmaceuticals and looks into why crucial pharmacovigilance practices …
Feature
scott_gottlieb

FDA Commissioner Scott Gottlieb announces resignation

March 8, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Scott Gottlieb, appointment, pharma

Dr Scott Gottlieb, the 23rd Commissioner of the US Food and Drug Administration (FDA), stoked surprise throughout the industry with …
Appointment
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

March 8, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Biogen, Gilead, HIV, Novartis, Scott Gottlieb, top 10

HIV hit the headlines this week after it was announced that a British man known only as the ‘London Patient’ …
News
alessandro_riva

Glenmark spinoff name Gilead VP Alessandro Riva as new CEO

March 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Gilead’s Dr Alessandro Riva, is stepping down from his position as the company’s Executive Vice President, Oncology Therapeutics to head …
Appointment
scott_gottlieb

FDA Commissioner Scott Gottlieb announces resignation

March 6, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Scott Gottlieb, opioid crisis, pharma

Dr Scott Gottlieb, the 23rd Commissioner of the US Food and Drug Administration (FDA), stoked surprise throughout the industry with …
News
antony_loebel

Sunovion CMO Dr Antony Loebel made company’s new CEO

March 5, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, CMO, Japan, medicine, psychiatry, sunovion

Japanese drugmaker Sunovion Pharmaceuticals has made their current Chief Medical Officer (CMO) the company’s new Chief Executive Officer (CEO). Dr …
Appointment
shutterstock_38078521

Akcea and Ionis’ Waylivra nets CHMP approval in ultra-rare familial chylomicronaemia syndrome

March 5, 2019 Manufacturing and Production, Sales and Marketing Akcea, FCS, Ionis, familial chylomicronemia syndrome, pharma, rare disease

Akcea Therapeutics and Ionis Pharmaceuticals have announced that their investigational therapy Waylivra (volanesorsen) has been recommended by the EMA’s Committee …
News
novartis_side_building

Novartis set to offer 14 weeks paternity leave

March 5, 2019 Manufacturing and Production Novartis, company culture, paternity leave, work

Novartis is planning to offer employees 14 weeks of parental leave, a move which would make the firm one of …
News
1920px-hiv-budding-color

London man becomes second in world to be cured of HIV

March 5, 2019 Manufacturing and Production Berlin Patient, CCR5, HIV, He Jiankui, London Patient

A man in Britain has become the second person in the world to be ‘cured’ of HIV, after receiving a …
News
novartis_side_building

Novartis’ Cosentyx tops Janssen’s Stelara in moderate-to-severe psoriasis trial

March 5, 2019 Manufacturing and Production, Research and Development Cosentyx, Janssen, Novartis, Stelara, pharma, psoriasis

New data has been revealed in support of Novartis’ Cosentyx (secukinumab) in the treatment of moderate-to-severe plaque psoriasis, demonstrating the …
News
920x920

OxyContin drugmaker Purdue Pharma exploring bankruptcy, sources say

March 4, 2019 Manufacturing and Production Litigation, Purdue Pharma, bankruptcy, opioid crisis, trials

OxyContin drugmaker Purdue Pharma is exploring the option of filing for bankruptcy. The news comes as the Connecticut-based firm faces …
News

The cutting edge of cancer research

March 4, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, feature, oncology

While immunotherapies continue to be the darling of the industry, new, innovative and sometimes seemingly fantastical research is emerging that …
Feature
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

March 1, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GP, Michael Cohen, Novartis, Roche, Sanofi, Senate, UK, crispr, top 10

As the CRISPR twins’ story unfolds, scientists revealed that the Chinese babies were likely altered in a way that improves …
News
8b437d43644106a4fb11aa4292aa6fbd_1

Working Life: Nicola Redfern, UK General Manager, bluebird bio

February 28, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bluebird Bio, Interview, Working Life, pharma

How did you find your way into the pharma industry? Was it always an aspiration of yours? My mum worked …
Feature
The Gateway to Local Adoption Series

Latest content

Ofichem brings all brands under single trading name

April 23, 2026

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026

Incyclix Bio announces new additions to the Board

April 22, 2026

Remedy Plan Therapeutics Appoints Jotin Marango as CFO and CBO

April 21, 2026